“Our assumption for academic and government embedded in our guidance is similar conditions to last year in aggregate.”

In context

“en relatedly, as we think about your analytical instrument end market, you know, the US academic market specifically there, Marc, at our conference a few weeks ago, you had talked about the expectation for US academic and government customers to really remain cautious until a finalized NIH budget is passed. And then for spending to increase thereafter. I guess, what's assumed for US academic and government growth in 2026? And really, how quickly would you expect spending to pick up after that budget is finalized? You know, last year, saw a bit of a discrepancy between fund appropriations and ultimate, you know, spending with tools. So just any further color on the expectations for US academic and government in 2026? Thanks. Marc Casper: Yeah. So, Casey, when I think let me first globally. Our assumption for academic and government embedded in our guidance is similar conditions to last year in aggregate. Right? And when I think about the US environment, our assumption here is that there'll be a level of customer caution that will probably abate as the year goes down, but I would still assume in our guidance it'll be a more cautious environment. As customers are navigating the landscape. You know, seems likely that we'll get a flat to slightly up NIH budget. That's gonna be a good point in time exactly when that happens, TBD. So that should create tailwinds. So when I think about over the next couple of years, I would expect that that will be one of the drivers of us higher in the range. But for now, our assumption is that relatively cautious for 2026. So thank you, Casey. Great. Operator, we have time for one more question. Operator: Thank you. Our last question comes from Dan Brennan fro”